MIT researchers see alternative to common colorectal cancer drug

A compound that accumulates in cells more readily than a commonly used colorectal cancer drug may be just as useful in treating colorectal tumors, but with fewer side effects, MIT researchers have found.

If you want to include this story in your blog, copy and paste this formatted text: